U.S. Markets closed
  • S&P 500

    3,699.12
    +32.40 (+0.88%)
     
  • Dow 30

    30,218.26
    +248.74 (+0.83%)
     
  • Nasdaq

    12,464.23
    +87.05 (+0.70%)
     
  • Russell 2000

    1,892.45
    +43.75 (+2.37%)
     
  • Crude Oil

    46.09
    +0.45 (+0.99%)
     
  • Gold

    1,842.00
    +0.90 (+0.05%)
     
  • Silver

    24.32
    +0.18 (+0.76%)
     
  • EUR/USD

    1.2127
    -0.0022 (-0.1819%)
     
  • 10-Yr Bond

    0.9690
    +0.0490 (+5.33%)
     
  • Vix

    20.79
    -0.49 (-2.30%)
     
  • GBP/USD

    1.3438
    -0.0015 (-0.1088%)
     
  • USD/JPY

    104.1400
    +0.2800 (+0.2696%)
     
  • BTC-USD

    18,837.02
    +44.23 (+0.24%)
     
  • CMC Crypto 200

    365.19
    -14.05 (-3.71%)
     
  • FTSE 100

    6,550.23
    +59.96 (+0.92%)
     
  • Nikkei 225

    26,751.24
    -58.13 (-0.22%)
     

Electronic Arts, Global Blood fall; Roku, T-Mobile rise

·1 min read

NEW YORK (AP) — Stocks that moved heavily or traded substantially Friday:

T-Mobile US Inc., up $6.30 to $123.56.

The wireless carrier handily beat Wall Street's third-quarter profit and revenue forecasts.

Electronic Arts Inc., down $9.14 to $119.19.

The maker of FIFA, Medal of Honor and other video games gave investors a disappointing revenue forecast.

Trade Desk Inc., up $172.04 to $819.34.

The digital-advertising platform blew past Wall Street's third-quarter profit forecasts.

Roku Inc., up $28.30 to $253.36.

The video streaming company reported a surge in active accounts and a surprising profit in the third quarter.

Cloudflare Inc., up $6.47 to $64.47.

The web security and content delivery company beat analysts' third-quarter earnings forecasts.

HubSpot Inc., up $43.84 to $380.05.

The cloud-based marketing and sales software platform reported a surge in new customers and strong third-quarter profits.

Marriott International Inc., up $2.98 to $103.89.

The hotel operator reported surprisingly good earnings as travel demand rebounded in China.

Global Blood Therapeutics Inc., down $22.11 to $38.21.

The biopharmaceutical company reported disappointing third-quarter earnings and revenue.